Long-Term Safety of Recombinant Human Growth Hormone in Turner Syndrome
Journal of Clinical Endocrinology and Metabolism, ISSN: 0021-972X, Vol: 93, Issue: 2, Page: 344-351
2008
- 101Citations
- 71Captures
- 3Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Turner syndrome (TS) affects more than 50,000 girls and women in the United States. The National Cooperative Growth Study (NCGS) has collected efficacy and safety data for 5220 TS children treated with recombinant human GH (rhGH) during the last 20 yr.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0021972X08601299; http://dx.doi.org/10.1210/jc.2007-1723; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=39049132175&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/18000090; https://academic.oup.com/jcem/article/93/2/344/2597952; https://dx.doi.org/10.1210/jc.2007-1723
The Endocrine Society
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know